NL-OMON52106已完成4 期
Prospective monitoring of immune response following COVID-19 vaccination in children with cancer - VACCinATE
Prinses Máxima Centrum voor Kinderoncologie0 个研究点目标入组 130 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 64（—）
入选标准
- •-Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine
- •as part of the national vaccination program (cohort I)
- •-Having received SARS-CoV-2 vaccination with Pfizer or Moderna as part of the
- •national vaccination program, with the last vaccination less than 6 weeks
- •before study entry (Cohort II + cohort III + cohort IV)
- •-Written informed consent
排除标准
- •-History of severe adverse reaction associated with a vaccine and/or severe
- •allergic reaction (e.g. anaphylaxis) to any component of the study
- •intervention(s).
- •-Not able to give informed consent (eg language problem, illiteracy)
研究者
相似试验
进行中（未招募）
1 期
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationEUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130
进行中（未招募）
1 期
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640
招募中
4 期
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndromeNL-OMON54387niversitair Medisch Centrum Utrecht640
已完成
4 期
Immune response following COVID-19 vaccination in children with cancer<tr><td>Childhood cancer, Corona vaccination, immune response</td></tr>Childhood cancer, Corona vaccination, immune response10047438NL-OMON21465Princess Máxima Center for Pediatric Oncology130
招募中
不适用
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20